Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Nucleolus02:55

The Nucleolus

8.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obesity-related thyroid reflections: from weight gain to weight loss.

European thyroid journal·2026
Same author

Modulation of chemokine secretion and oxidative stress <i>in vitro</i> in thyroid cells after exposure to thiocyanate, nitrate, or perchlorate.

Frontiers in endocrinology·2026
Same author

Recurrence risk of differentiated thyroid cancer treated with total or hemithyroidectomy: systematic review and meta-analysis.

European thyroid journal·2026
Same author

Integrating Advanced Endoscopic Techniques and Confocal Microscopy for Early Detection of Extrahepatic Cholangiocarcinoma.

Cancers·2026
Same author

Site-specific fracture risk in chronic hypoparathyroidism: systematic review and meta-analysis.

Reviews in endocrine & metabolic disorders·2026
Same author

Double pyramidal lobe detected at ultrasound: a case report with review of the literature.

Frontiers in surgery·2026

Related Experiment Video

Updated: Jun 11, 2025

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

1.7K

Beyond Malignancy Risk Stratification: FNAC Report Anticipates Thyroid Cancer Staging. Insights From Recent Studies.

Mario Rotondi1,2, Mayumi Endo3, Marsida Teliti1,2

  • 1Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.

The Journal of Clinical Endocrinology and Metabolism
|October 1, 2024
PubMed
Summary

Fine-needle-aspiration-cytology (FNAC) for thyroid nodules can yield indeterminate results. Indeterminate thyroid nodules (ITN) with cancer show a less aggressive clinical presentation compared to suspicious or malignant diagnoses.

Keywords:
ATA-riskFNACindeterminate nodulesthyroidthyroid cancer

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.6K
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

488

Related Experiment Videos

Last Updated: Jun 11, 2025

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

1.7K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.6K
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

488

Area of Science:

  • Endocrinology
  • Cytopathology
  • Oncology

Background:

  • Fine-needle-aspiration-cytology (FNAC) is a standard diagnostic tool for thyroid nodules.
  • A significant proportion of FNAC results are indeterminate (ITN), often requiring surgery.
  • Previous studies suggested variations in thyroid cancer (TC) behavior based on FNAC findings.

Purpose of the Study:

  • To discuss and provide perspective on recent findings regarding the clinical behavior of thyroid cancer with indeterminate FNAC results.
  • To compare the clinical presentation of thyroid cancer initially diagnosed as ITN versus those diagnosed as suspicious or malignant.
  • To explore the implications of these findings for patient management and treatment strategies.

Main Methods:

  • A commentary involving experts and cytologists not part of the original studies.
  • Review and synthesis of data from two independent studies (Europe and US) on thyroid cancer clinical behavior.
  • Comparison of outcomes based on different cytology classification systems (Italian and Bethesda).

Main Results:

  • Thyroid cancer (TC) with an initial indeterminate thyroid nodule (ITN) diagnosis exhibits a less aggressive clinical phenotype.
  • Lower rates of lymph node metastasis, aggressive variants, and BRAFV600E mutations were observed in ITN-diagnosed TC.
  • These findings were consistent across both European and US studies, regardless of classification system.

Conclusions:

  • Preoperative diagnosis of ITN in thyroid cancer is associated with a more indolent clinical course compared to suspicious or malignant diagnoses.
  • These results have significant clinical relevance for endocrinologists and cytologists.
  • The findings support exploring less aggressive therapeutic approaches for thyroid cancer initially classified as ITN.